Skip to main navigation
Skip to search
Skip to main content
Bond University Research Portal Home
Help & FAQ
Home
Profiles
Research units
Research Outputs
Student theses
Datasets
Activities
Press/Media
Projects
Search by expertise, name or affiliation
Biologic agents and tuberculosis
Claudia C. Dobler
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
79
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biologic agents and tuberculosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tuberculosis
100%
Biological Agents
100%
Latent Tuberculosis Infection
50%
Tuberculin Skin Test
50%
Anti-tumor Necrosis Factor (anti-TNF)
50%
Tumour Necrosis Factor Inhibitor (TNFi)
37%
Interferon-gamma Release Assay
37%
Infection Diagnosis
25%
Screening Test
12%
Screening Program
12%
Relative Risk
12%
High Specificity
12%
Repeated Testing
12%
Vaccination
12%
Inhibitor Treatment
12%
Reintroduction
12%
Immunocompromised Patients
12%
Tuberculosis Incidence
12%
Immunosuppressive Therapy
12%
Bacillus Calmette
12%
Immune-mediated Inflammatory Diseases
12%
Immune Reconstitution
12%
Infliximab
12%
Screening Algorithm
12%
New Tumor
12%
Adalimumab
12%
Disease Therapy
12%
Immunology and Microbiology
Infection
100%
Tumor Necrosis Factor Alpha
100%
Mantoux Test
100%
Interferon Gamma
75%
TNF Inhibitor
75%
Biological Product
50%
Screening Test
25%
Immune-Mediated Inflammatory Diseases
25%
Immune Reconstitution Inflammatory Syndrome
25%
Infliximab
25%
Adalimumab
25%
Immunosuppressive Therapy
25%
Medicine and Dentistry
Tumor Necrosis Factor
100%
Mantoux Test
100%
TNF Inhibitor
75%
Interferon Gamma Release Assay
75%
Biological Product
50%
Screening Test
25%
Combination Therapy
25%
Immunosuppressive Treatment
25%
Inflammatory Disorder
25%
Latent Tuberculosis
25%
Immune Reconstitution Inflammatory Syndrome
25%
Adalimumab
25%
Infliximab
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Tuberculin
100%
Gamma Interferon
75%
Tumor Necrosis Factor Inhibitor
75%
Biological Product
50%
Inflammatory Disease
25%
Immunosuppressive Agent
25%
Latent Tuberculosis
25%
Infliximab
25%
Adalimumab
25%
Immune Reconstitution Inflammatory Syndrome
25%